Evaluation of the Efficiency of the Technology-Based Psychosocial Empowerment Program Program
1 other identifier
interventional
72
1 country
1
Brief Summary
This research was planned to evaluate the effectiveness of the technology-based psychosocial empowerment program for home care for children aged 8-18 years with cancer and their parents as a parallel-group randomized controlled study design.The required institutional permission and ethics committee approval was received.The study group of the study consisted of 72 children and parents (intervention group \[n=36\], control group \[n=36\]). Data were collected using the descriptive features form, the General Self-Efficacy Scale-Pediatric Cancer Version, the State and Trait Anxiety Inventory for Children, the Pediatric Cancer Coping Scale, the General Self-Efficacy Scale for parents, the Problem-Solving Scale, and the Cope and Adaptatıon Process Scale. The data were stored in the SPSS 25 program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2023
CompletedFirst Posted
Study publicly available on registry
April 10, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedApril 10, 2023
March 1, 2023
1 year
March 29, 2023
March 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
General Self-Efficacy Scale-Pediatric Cancer Version
It is a one-dimensional, 10-item scale used to evaluate self-efficacy in children aged 8-18 years with cancer.As the score obtained from the scale increases, the level of self-efficacy also increases.
Change from Baseline level 'Self Efficacy' to 2 months (change is being assessed)
State-Trait Anxiety Inventory for Children
The 'State Anxiety Scale' for children between the ages of 8-18 was created to determine what the child feels at that moment, and the 'Trait Anxiety Scale' was created to determine what they usually feel. The higher the score, the higher the anxiety level.
Change from Baseline level 'State-Trait Anxiety' to 2 months (change is being assessed)
Pediatric Cancer Coping Scale
It was developed to evaluate coping in children aged 7-18 years with cancer diagnosis. The scale consists of 3 sub-dimensions as cognitive coping, problem-focused coping and defensive coping. The higher the score, the higher the coping strategies.
Change from Baseline level 'Pediatric Cancer Coping Scale' to 2 months (change is being assessed)
General Self-Efficacy Scale
It is a one-dimensional scale developed to evaluate the general self-efficacy level of adults.As the score obtained from the scale increases, the level of self-efficacy also increases.
Change from Baseline level 'Self Efficacy' to 2 months (change is being assessed)
Problem Solving Inventory
It is a scale that measures the problem solving skills of individuals according to the perception of the individual.The inventory consists of three sub-dimensions: Safe in Problem Solving, Approach Avoidance Style and Personal Control.Low scores from the inventory indicate the ability to produce effective solutions to problems, while high scores indicate the inability to find effective solutions to problems.
Change from Baseline level 'Problem Solving Inventory' to 2 months (change is being assessed)
Coping and Adaptation Process Scale
The scale is a scale that enables individuals to define coping and adaptation strategies in critical and difficult situations. The scale consists of 47 items and five sub-dimensions. Scale items are scored between 1 and 4. As the score obtained from the scale and subscales increases, it is interpreted as the use of effective coping methods increases.
Change from Baseline level 'Coping and Adaptation Process Scale' to 2 months (change is being assessed)
Secondary Outcomes (1)
SSPedi: Symptom Screening Scale in Pediatric Patients
While the intervention continues (1 months), the log records of the scale on the website will be evaluated.
Study Arms (2)
Experimental group
EXPERIMENTAL-The experimental group that applied the technology-based psychosocial program
Control group
NO INTERVENTIONControl group receiving standard care
Interventions
A technology-based model-based psychosocial empowerment program will be implemented for parents and children in the control group.
Eligibility Criteria
You may qualify if:
- For children's:
- Children between the ages of 8-18, Those receiving cancer treatment (leukemias and solid tumors) and completing the first 2 months of the treatment process, Children with tablets, android phones and internet access Children whose parents and themselves agree to participate in the study, Children who can continue the study for 4-6 weeks,
- For primary care parents, Parents who can speak Turkish, Parents who can use computers and android mobile phones, Parents who agreed to participate in the study, Parents who can continue the study for 4-6 weeks,
You may not qualify if:
- Newly diagnosed children (in induction phase), Children who are in the terminal period or who are treated for relapse, Presence of another important disease (such as chronic disease, psychiatric diagnosis) in the family that may prevent coping, other than the child followed up with the diagnosis of cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hazal Ozdemir Koyu, MD
Gazi University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- In the research, it was planned to blind the participant and outcome evaluation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
March 29, 2023
First Posted
April 10, 2023
Study Start
September 1, 2023
Primary Completion
September 1, 2024
Study Completion
November 1, 2024
Last Updated
April 10, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
There are no plans to make individual participant data (IPD) available to other researchers